Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected] Learn more

(Plasmid #83503)


Item Catalog # Description Quantity Price (USD)
Plasmid 83503 Standard format: Plasmid sent in bacteria as agar stab 1 $85

This material is available to academics and nonprofits only.


Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
  • Growth Strain(s)
  • Copy number


  • Gene/Insert name
  • Alt name
    hepatocyte growth factor
  • Species
    M. musculus (mouse)
  • Mutation
    also contains beta-globin sequences from pUC198
  • Entrez Gene
    Hgf (a.k.a. C230052L06Rik, HGF/SF, NK1, NK2, SF, SF/HGF)
  • Promoter mouse WAP (whey acidic protein)

Cloning Information

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pWAP-HGF was a gift from Marta Gallego & Lothar Hennighausen (Addgene plasmid # 83503 ; ; RRID:Addgene_83503)
  • For your References section:

    Targeted expression of HGF/SF in mouse mammary epithelium leads to metastatic adenosquamous carcinomas through the activation of multiple signal transduction pathways. Gallego MI, Bierie B, Hennighausen L. Oncogene. 2003 Nov 20;22(52):8498-508. 10.1038/sj.onc.1207063 PubMed 14627990